Patent details

EP1917528 Title: BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS

Basic Information

Publication number:
EP1917528
PCT Application Number:
PCT/US/2006/033073
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068137025
PCT Publication Number:
WO/2007/025044
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO EPIDERMAL GROWTH FACTOR RECEPTOR MODULATORS
French Title of Invention:
MARQUEURS BIOLOGIQUES ET PROCEDES PERMETTANT DE DETERMINER LA RECEPTIVITE AUX MODULATEURS DU RECEPTEUR DU FACTEUR DE CROISSANCE EPIDERMIQUE (EGFR)
German Title of Invention:
BIOMARKER UND VERFAHREN ZUR BESTIMMUNG DER EMPFINDLICHKEIT GEGENÜBER MODULATOREN DES EGF(EPIDERMAL GROWTH FACTOR)-REZEPTORS
SPC Number:

Dates

Filing date:
24/08/2006
Grant date:
17/08/2011
EP Publication Date:
17/08/2011
PCT Publication Date:
01/03/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/05/2008
EP B1 Publication Date:
17/08/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/08/2011
Expiration date:
24/08/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/08/2006
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543-4000, United States (US)

Inventor

1

Name:
CLARK Edwin A.
Address:
United States (US)

2

Name:
HUANG Xin
Address:
United States (US)

3

Name:
FORD Shirin K.
Address:
United States (US)

Priority

Priority Number:
711054 P
Priority Date:
24/08/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/48;
Filing date Document type Number of pages